Sign in to view content

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Michael S. Ip, MD

Video
Published 2018

Related

A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018
Post-Hoc Fellow Eye Analyses Support SAKURA Program Findings on Vitreous Haze, Visual Acuity and Macular Edema in Noninfectious Uveitis
Pauline T. Merrill, MD, FASRS
On Demand Cases, Courses, and Papers
2018
The Use of Swept Source Optical Coherence Tomography Angiography (SS-OCTA) in Patients With Uveitis and Retinal Vasculitis
Sumit Sharma, MD, FASRS
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more